NDA leaders convened at BJP headquarters to strategize for the ongoing assembly elections in Maharashtra and Jharkhand, as well as upcoming electoral challenges... IndiaTimes
A Delhi court extended AAP MLA Amanatullah Khan's judicial custody till November 16 in the Delhi Waqf Board money laundering case. The Enforcement Directorate.. IndiaTimes
The Supreme Court emphasized the need to manage pollution caused by firecrackers, cautioning that unchecked pollution contributes to disorder and health risks. DNA
In areas like Punjabi Bagh, Wazirpur, Ashok Vihar, Bawana, Jahangirpuri, Mundka, Rohini, Moti Bagh, and Patparganj, the air quality worsened with AQI hit the.. DNA
A new intranasal vaccine developed by researchers at the Wuhan lab has recently been unveiled, promising a novel approach to combating infectious diseases. However, this breakthrough has also sparked significant controversy and concern. While the vaccine’s potential to offer a more accessible and efficient method of vaccination is hailed as a major advancement, its origins and the circumstances surrounding its development are raising alarms about a possible new health crisis. Critics worry that the technology used in this vaccine could inadvertently lead to another pandemic-like scenario if not carefully monitored. As the world cautiously watches, the vaccine's rollout is stirring a heated debate about safety, preparedness, and the ethical implications of such advanced biological research.
#IntranasalVaccine #WuhanLab #CovidCrisis #HealthFears #VaccineDebate #PandemicRisk #BioResearch #VaccineDevelopment #PublicHealth #InfectiousDiseases #SafetyConcerns #GlobalHealth #VaccineInnovation #EthicalIssues #HealthSecurity
~HT.97~PR.152~
It's time people start wearing masks inside their homes as well, advised Member-Health of NITI Aayog, Dr. VK Paul, on April 26 while addressing a press conference in Delhi over second wave of COVID-19...
Addressing rumours suggesting women shouldn't taken vaccine during menstruation, NITI Aayog Member-Health, Dr. VK Paul said that the vaccine can be taken during periods and it is no reason to postpone..
Member of NITI Aayog, Dr. VK Paul on April 19 said that the production of Remdesivir would be aimed at scaling up to 76 lakh vials per month. Dr. VK Paul said, "Air-borne transmission is more prevalent..